Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China · Delayed Price · Currency is CNY 6.18
+0.03 (0.49%)
At close: Feb 13, 2026
Shanghai Kinetic Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,000 | 962.74 | 933.63 | 1,146 | 1,258 | 1,050 |
Other Revenue | 21.78 | 21.78 | 22.63 | 19.77 | 10.44 | 12.02 |
| 1,022 | 984.52 | 956.26 | 1,166 | 1,269 | 1,062 | |
Revenue Growth (YoY) | 5.39% | 2.96% | -17.99% | -8.08% | 19.50% | -13.15% |
Cost of Revenue | 502.31 | 505.43 | 466.09 | 425.97 | 490.52 | 357.86 |
Gross Profit | 519.94 | 479.09 | 490.17 | 740.07 | 778.06 | 703.72 |
Selling, General & Admin | 384.79 | 348.72 | 353.05 | 436.31 | 406.76 | 382.36 |
Research & Development | 40.88 | 43.3 | 59.34 | 61.4 | 69.77 | 46.64 |
Other Operating Expenses | 14.81 | 5.56 | 6.97 | 10.44 | 9.67 | 8.84 |
Operating Expenses | 446.43 | 399.97 | 410.4 | 527.81 | 497.7 | 448.84 |
Operating Income | 73.51 | 79.12 | 79.78 | 212.26 | 280.36 | 254.88 |
Interest Expense | -9.35 | -6.67 | -6.56 | -14.12 | -22.66 | -22.39 |
Interest & Investment Income | 10.11 | 8.17 | 46.47 | 16.56 | 27.8 | 19.89 |
Currency Exchange Gain (Loss) | -0.53 | -0.53 | 0.48 | -2.33 | 1.12 | -2.06 |
Other Non Operating Income (Expenses) | -3.84 | -3.37 | -4.26 | -4.17 | -2.76 | -4.88 |
EBT Excluding Unusual Items | 69.9 | 76.73 | 115.9 | 208.2 | 283.86 | 245.45 |
Impairment of Goodwill | - | - | - | -197.99 | -149.26 | -365.59 |
Gain (Loss) on Sale of Investments | -181.25 | -195.07 | 1.19 | -28.9 | 35.25 | 1.53 |
Gain (Loss) on Sale of Assets | -0.19 | -0.1 | -0.37 | 0.21 | 1.6 | 0.09 |
Asset Writedown | -17.83 | -2.91 | -0.58 | -2.01 | -0.14 | -0.04 |
Other Unusual Items | 15.71 | 10.99 | 17.44 | 18.23 | 44.93 | 31.29 |
Pretax Income | -113.67 | -110.37 | 133.57 | -2.26 | 216.31 | -87.27 |
Income Tax Expense | -18.11 | -14.15 | 6.98 | 21.69 | 41.31 | 37.68 |
Earnings From Continuing Operations | -95.56 | -96.22 | 126.6 | -23.95 | 175 | -124.95 |
Minority Interest in Earnings | 5.18 | -9.35 | -14.06 | 2.67 | -13.22 | -1.59 |
Net Income | -90.38 | -105.57 | 112.54 | -21.28 | 161.78 | -126.54 |
Net Income to Common | -90.38 | -105.57 | 112.54 | -21.28 | 161.78 | -126.54 |
Shares Outstanding (Basic) | 717 | 717 | 717 | 719 | 722 | 723 |
Shares Outstanding (Diluted) | 717 | 717 | 717 | 719 | 722 | 723 |
Shares Change (YoY) | 0.36% | 0.05% | -0.31% | -0.40% | -0.16% | 0.19% |
EPS (Basic) | -0.13 | -0.15 | 0.16 | -0.03 | 0.22 | -0.17 |
EPS (Diluted) | -0.13 | -0.15 | 0.16 | -0.03 | 0.22 | -0.17 |
Free Cash Flow | 98.31 | 74.91 | 220.47 | 195.3 | 328.94 | 255.32 |
Free Cash Flow Per Share | 0.14 | 0.10 | 0.31 | 0.27 | 0.46 | 0.35 |
Dividend Per Share | - | - | 0.060 | - | 0.050 | 0.050 |
Gross Margin | 50.86% | 48.66% | 51.26% | 63.47% | 61.33% | 66.29% |
Operating Margin | 7.19% | 8.04% | 8.34% | 18.20% | 22.10% | 24.01% |
Profit Margin | -8.84% | -10.72% | 11.77% | -1.82% | 12.75% | -11.92% |
Free Cash Flow Margin | 9.62% | 7.61% | 23.06% | 16.75% | 25.93% | 24.05% |
EBITDA | 109.73 | 128.03 | 145.6 | 273.16 | 337.18 | 287.94 |
EBITDA Margin | 10.73% | 13.00% | 15.23% | 23.43% | 26.58% | 27.12% |
D&A For EBITDA | 36.22 | 48.91 | 65.83 | 60.9 | 56.81 | 33.06 |
EBIT | 73.51 | 79.12 | 79.78 | 212.26 | 280.36 | 254.88 |
EBIT Margin | 7.19% | 8.04% | 8.34% | 18.20% | 22.10% | 24.01% |
Effective Tax Rate | - | - | 5.22% | - | 19.10% | - |
Revenue as Reported | 1,022 | 984.52 | 956.26 | 1,166 | 1,269 | 1,062 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.